RecruitingNCT06340152

Multi-Omics for Maternal Health After Preeclampsia

Sponsor

University of California, San Diego

Enrollment

1,100 participants

Start Date

Dec 20, 2023

Study Type

OBSERVATIONAL

Conditions

Pre-Eclampsia Pregnancy-induced Hypertension

Summary

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study collects biological samples and health data from pregnant women during and after pregnancy to understand why some women develop preeclampsia (dangerously high blood pressure during pregnancy) and how it affects long-term heart health, using advanced multi-omics analysis (studying genes, proteins, and other biological data together). **You may be eligible if...** - You are 18 to 50 years old - You are 10 to 24 weeks pregnant at enrollment - You are carrying a single baby - You plan to deliver at UC San Diego or Vanderbilt University Medical Center **You may NOT be eligible if...** - You are unable to give informed consent - Your baby has a known chromosomal or structural abnormality, or the pregnancy has ended - You have a history of cancer requiring major surgery or chemotherapy - You are carrying multiples (twins, triplets, etc.) - You have a known chromosomal abnormality (mother or baby) - You plan to keep your placenta after delivery - You are institutionalized for a psychiatric condition or incarcerated Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.